BGI Genomics major shareholder adjusts pledged holdings

Shenzhen BGI Genomics Co., Ltd. announced that Shenzhen Shenghua Investment Enterprise (Limited Partnership), a shareholder holding over 5% of the company's shares, has completed the release and re-pledge of a portion of its stock. On September 19, 2024, Shenghua Investment released 4,850,000 pledged shares, representing 15.23% of its total holdings and 1.16% of the company's total share capital.

Concurrently, Shenghua Investment re-pledged 2,800,000 shares, accounting for 9.24% of its total holdings and 0.67% of the company's total share capital. This new pledge commenced on September 12, 2025, and will extend until the completion of the release of the pledge registration procedures. Both operations were handled by the China Securities Depository and Clearing Corporation Limited Shenzhen Branch, with China Construction Bank Shenzhen Eastern Branch acting as the pledgee.

Following these adjustments, Shenghua Investment’s total pledged shares now stand at 26,250,000, which constitutes 86.67% of its total holdings and 6.28% of BGI Genomics’ total share capital. BGI Genomics confirmed there is no imminent risk of liquidation, and the pledge risk remains manageable.